Bendeka 100 mg/4 mL injection for intravenous infusion Images
Generic Name: bendamustine
This medication has been identified as Bendeka 100 mg/4 mL injection for intravenous infusion. It is supplied by Teva Pharmaceuticals USA, Inc.
Bendeka is used in the treatment of Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Bendeka 100 mg/4 mL injection for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Bendeka
- Generic Name
- bendamustine
- Strength
- 100 mg/4 mL injection for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 63459-0348
More about Bendeka (bendamustine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
